BioLineRx Ltd.

BLRX chart

BioLineRx Ltd. news

• BioLineRX Ltd. Estimates – TASE:BLRX

  TradingView · Oct 24, 7:34 AM EDT

• BioLineRx, Hemispherian report GLIX1 data at ESMO 2026

  Investing.com · Oct 23, 7:26 AM EDT

• A 28-day animal study compares BioLineRx (BLRX)'s ovarian cancer drug combination with single treatments.

  Stock Titan · Oct 23, 7:05 AM EDT

• BioLineRx and Hemispherian Present Preclinical Data Demonstrating Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancer at ESMO 2026

  Yahoo Finance · Oct 23, 7:00 AM EDT

• BioLineRx and Hemispherian Announce Two GLIX1 Presentations at the 31st Society for Neuro-Oncology (SNO) Annual Meeting & Education Day

  Yahoo Finance · Oct 8, 7:00 AM EDT

• BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026)

  Yahoo Finance · Sep 10, 7:00 AM EDT

• BLRX: New GLIX1 Data Touts Synergies

  Yahoo Finance · Sep 1, 8:05 AM EDT

• BioLine Rx Ltd (BLRX) (Q2 2026) Earnings Call Highlights: Advancing GLIX1 Pipeline and ...

  Yahoo Finance · Aug 31, 5:00 PM EDT

• BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update

  Yahoo Finance · Aug 31, 7:00 AM EDT

• BioLineRx Announces $3.75 Million Registered Direct Offering and Concurrent Private Placement

  Yahoo Finance · Aug 28, 8:00 AM EDT

• BioLineRx to Report Second Quarter 2026 Results on August 31, 2026

  Yahoo Finance · Aug 25, 7:00 AM EDT

• BioLineRx and Hemispherian AS to Present Data Demonstrating Strong Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancers at ESMO 2026

  Yahoo Finance · Jul 20, 7:00 AM EDT

BioLineRx Ltd. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-10-23
• 6-K6-K2026-09-24
• 6-K6-K2026-09-10
• 6-K6-K2026-08-31
• 6-K6-K2026-08-31
• 6-K6-K2026-08-28
• 6-K6-K2026-08-18
• 6-K6-K2026-07-08
• 6-K6-K2026-05-27
• 6-K6-K2026-05-22
• 6-K6-K2026-05-19
• 6-K6-K2026-04-28

About BioLineRx Ltd.

Ticker

BLRX (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Modi-In

Incorporated in

Israel

Fiscal year end

December 31

SEC CIK

1498403

Frequently asked questions